Connor, Clark & Lunn Investment Management (CC&L)’s Atossa Therapeutics ATOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $165K | Buy |
198,668
+9,349
| +5% | +$7.76K | ﹤0.01% | 1434 |
|
|
2025
Q1 | $127K | Hold |
189,319
| – | – | ﹤0.01% | 1348 |
|
|
2024
Q4 | $179K | Sell |
189,319
-10,435
| -5% | -$9.85K | ﹤0.01% | 1337 |
|
|
2024
Q3 | $304K | Sell |
199,754
-9,487
| -5% | -$14.4K | ﹤0.01% | 1234 |
|
|
2024
Q2 | $249K | Buy |
209,241
+56,116
| +37% | +$66.8K | ﹤0.01% | 1225 |
|
|
2024
Q1 | $276K | Buy |
153,125
+32,797
| +27% | +$59K | ﹤0.01% | 1299 |
|
|
2023
Q4 | $106K | Sell |
120,328
-13,263
| -10% | -$11.7K | ﹤0.01% | 1319 |
|
|
2023
Q3 | $98.4K | Buy |
+133,591
| New | +$98.4K | ﹤0.01% | 1292 |
|
|
2023
Q1 | – | Sell |
-17,967
| Closed | -$9.5K | – | 1238 |
|
|
2022
Q4 | $9.5K | Buy |
+17,967
| New | +$9.5K | ﹤0.01% | 1174 |
|